Cleveland HeartLab Adds New Patent to its Extensive Intellectual Property Position for the Myeloperoxidase (MPO) Test, a Powerful Biomarker for Inflammation and its Role in Major Cardiac Events
Cleveland HeartLab Inc. (CHL), the premier cardiovascular disease (CVD) management company, announced today that a new patent for Myeloperoxidase (MPO) testing has been issued, U.S. Patent No. 9,575,065.
Introducing the Inaugural Medical Capital Innovation Competition
The Global Center for Health Innovation (GCHI), Cuyahoga County, BioEnterprise, and HIMSS (Healthcare Information and Management Systems Society) are pleased to announce the inaugural Medical Capital Innovation Competition - All Things Data in Healthcare -- a two-day event to be held in the HIMSS Innovation Center at the GCHI, Cleveland, OH, April 25-26, 2017. The Medical Capital Innovation Competition is open to and encourages participation from professional and collegiate teams. $100,000 in prizes, mentoring, and access to business advisors, including world-class healthcare systems and collaborators, will be awarded.
Surgical startup poised to enter market
Cleveland-based surgical navigation startup Centerline Biomedical Inc. is gearing up to enter the market in 2017 with its GPS-like system that provides 3-D guidance during endovascular surgery.
Cleveland Clinic doctors perform groundbreaking stroke surgery
The Cleveland Clinic has performed what it calls the "first deep brain stimulation surgery for stroke recovery," which it says is part of an ongoing clinical trial assessing the procedure's potential to improve movement in patients recovering from stroke.
Ringing in the New Year: Medical Innovations for 2017
What exciting new medical developments can we look forward to in 2017? To answer this question, the Cleveland Clinic assembled a group of more than 100 physicians and leading researchers, who identified the top 10 medical innovations anticipated to have the greatest impact. The final list was unveiled at the Cleveland Clinic's annual Medical Innovation Summit.1
Experimental transcatheter tricuspid stent implanted into patient at Cleveland Clinic
A new transcatheter tricuspid valved stent was successfully implanted into a patient at the Cleveland Clinic to treat tricuspid regurgitation, a disease grossing billions of dollars in treatments annually.
Bioresorbable stents make Cleveland Clinic’s Top 10 innovations for 2017
The Cleveland Clinic named bioresorbable stents as one of the top 10 medical innovations for 2017.
Centerline Biomedical Rounds Up Successful Year With Series A Fundraising
CLEVELAND, Dec. 13, 2016 /PRNewswire/ -- Surgical navigation startup Centerline Biomedical, Inc. closed a Series A funding round in December 2016. This significant milestone comes on the heels of several preclinical studies and builds upon successful financing and outreach achieved over the course of 2016, driving the company forward in its commercialization mission.
Innovation can pave the road ahead for health reform | Opinion
The struggle to bring about health reform in the United States — greater access, better outcomes, reduced cost — has been a long and winding road. And the outcome of the presidential election this year has some in the health care industry fearing more obstacles ahead.
Why Cleveland Is America's Hottest City Right Now
LeBron James famously declared after the Cleveland Cavaliers won their first NBA title this past June that “It’s Cleveland Against The World”.
If you haven’t been paying attention since then, Cleveland is still on a winning roll. And I’m not just talking about the Cavs or the Indians, who are playing the Chicago Cubs in the World Series this week vying to win their first baseball championship in 68 years. This past July, every hotel room downtown was sold out for the week when the Republican National Convention came to town.